TheraSphere Y-90 Glass Micropheres (yttrium-90 microspheres)
pCPA File Number:
23040
Negotiation Status:
Concluded with an LOI
Indication(s):
As selective internal radiation therapy (SIRT) for local tumor control of solitary tumors in patients with intermediate- or advanced-stage hepatocellular carcinoma (HCC), including those with recurrent or unresectable HCC. In addition to HCC
Sponsor/Manufacturer:
Boston Scientific Corporation
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: